Speculation Abounds As Biden Is Slow To Nominate FDA Head

By Emily Field (April 13, 2021, 8:02 PM EDT) -- Almost 100 days into the Biden administration, the clock is still ticking for the president to nominate a commissioner for the U.S. Food and Drug Administration, an agency that's been rocked by controversy the past year amid the coronavirus pandemic.

Whoever does ultimately step into the role will take on a high-pressure job facing a trio of challenges: the pandemic, the opioid crisis, and low morale at the agency in the wake of attacks and Twitter jabs from former President Donald Trump, who last year accused the FDA of a "political hit job" when it became apparent a coronavirus vaccine wouldn't...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!